Streetbeat News

Stock Prices

MRK

MRNA

MYNZ

PFE

Promising trial results from Pfizer, Moderna, Merck, and Mainz Biomed indicate potential new standards in cancer treatment and diagnostics. Pfizer's Lorbrena shows significant long-term benefits for lung cancer patients, while Moderna and Merck's combined melanoma treatment demonstrates durable efficacy. Mainz Biomed's ColoAlert® test for colorectal cancer also shows high sensitivity and specificity.

Portfolio Pulse from Upwallstreet

June 04, 2024 | 5:45 pm

BLBD

CLNE

VLVLY

Natural gas prices have hit record lows, leading to lower heating bills and potential impacts on natural gas vehicle markets. Companies like Blue Bird Corp, Volvo ADR, and Clean Energy Fuels Corp are directly affected.

Portfolio Pulse from Hayden Buckfire

June 04, 2024 | 5:44 pm

CELH

MNST

A recent article suggests that ingredients in popular energy drinks like Red Bull, Celsius, and Monster may be linked to gut bacteria that accelerate tumor growth, potentially contributing to a colon cancer crisis among young people.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:43 pm

CORT

Corcept Therapeutics shares are trading higher after Truist Securities reiterated a Buy rating on the stock and raised its price target from $44 to $65.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 5:41 pm

WULF

TeraWulf Inc. (NASDAQ:WULF) shares are trading higher after the company provided an unaudited monthly production and operations update for May 2024. The company self-mined 186 bitcoin in May, with an average production rate of 6 bitcoin per day. Power costs averaged $31,239 per bitcoin. TeraWulf's installed and operational self-mining capacity reached 8.0 EH/s, an 82% year-over-year increase. The company is also making progress on new facilities that will further increase capacity. Analysts have a positive outlook on the stock with an average 12-month price target of $3.78.

Portfolio Pulse from Erica Kollmann

June 04, 2024 | 5:37 pm

PHUN

Phunware, Inc. (NASDAQ:PHUN) shares are down 10.1% to $5.70 after announcing a multi-million dollar equity distribution agreement with Canaccord Genuity LLC and other investment banks. The company may offer and sell shares for up to $120 million in aggregate gross proceeds. Despite recent contract renewals in healthcare and hospitality, PHUN stock has lost over 80% in the past year.

Portfolio Pulse from Nabaparna Bhattacharya

June 04, 2024 | 5:34 pm

NDRA

ENDRA Life Sciences Inc (NASDAQ:NDRA) shares plummeted by 65% to $0.07 due to a public offering of 61,538,461 shares of common stock with accompanying Series A and Series B warrants. The offering is in a 'best-efforts' format, meaning no guaranteed amount of money raised. The proceeds will be used for general business purposes. The stock has lost 94.95% year to date and has an RSI of 14.7, indicating oversold conditions.

Portfolio Pulse from Henry Khederian

June 04, 2024 | 5:34 pm

TXT

Textron (NYSE:TXT) has outperformed the market over the past 15 years with an average annual return of 14.43%, surpassing the market by 2.29% annually. A $1000 investment in Textron 15 years ago would be worth $7,226.78 today.

Portfolio Pulse from Benzinga Insights

June 04, 2024 | 5:30 pm

AZN

AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years, delivering an average annual return of 15.01%. A $1000 investment in AZN 5 years ago would be worth $2,041.26 today. The article highlights the impact of compounded returns on cash growth.

Portfolio Pulse from Benzinga Insights

June 04, 2024 | 5:30 pm

GME

Massachusetts' top securities regulator is investigating Keith Gill, known as 'Roaring Kitty,' for potential manipulation in his recent GameStop trading activities. E-Trade is considering banning Gill from its platform. The U.S. SEC is also looking into recent options trading in GameStop. GameStop stock fell over 3% following the news.

Portfolio Pulse from Adam Eckert

June 04, 2024 | 5:29 pm